E
Ennio Tasciotti
Researcher at Houston Methodist Hospital
Publications - 216
Citations - 9469
Ennio Tasciotti is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Drug delivery & Tissue engineering. The author has an hindex of 42, co-authored 212 publications receiving 7526 citations. Previous affiliations of Ennio Tasciotti include University of Akron & Open University.
Papers
More filters
Journal ArticleDOI
Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release.
Francesca Taraballi,Francesca Taraballi,Silvia Minardi,Silvia Minardi,Bruna Corradetti,Bruna Corradetti,Iman K. Yazdi,Iman K. Yazdi,Marta A Balliano,Jeffrey L. Van Eps,Massimo Allegri,Ennio Tasciotti +11 more
TL;DR: The ability to develop a drug delivery system capable of controlled release of local anesthetics to treat acute/subacute pain while concurrently avoiding enhanced inflammation is demonstrated.
Journal ArticleDOI
Biocompatible PLGA-Mesoporous Silicon Microspheres for the Controlled Release of BMP-2 for Bone Augmentation
Silvia Minardi,Joseph S. Fernandez-Moure,Dongmei Fan,Matthew B. Murphy,Iman K. Yazdi,Xuewu Liu,Bradley K. Weiner,Ennio Tasciotti +7 more
TL;DR: The biocompatible, biodegradable, and osteogenic PLGA-MSVs system could be an ideal candidate for the safe use of BMP-2 in orthopedic tissue engineering applications.
Journal ArticleDOI
Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity
Erin D. Wenzel,Alessia Bachis,Valeriya Avdoshina,Francesca Taraballi,Ennio Tasciotti,Italo Mocchetti +5 more
TL;DR: It is established that once internalized, gp120 is neurotoxic regardless of chemokine receptor activation, and the data suggest that dynamin-dependent endocytosis ofgp120 is critical for its neurotoxicity.
Journal ArticleDOI
Patterning Biomaterials for the Spatiotemporal Delivery of Bioactive Molecules.
TL;DR: This review will present the most recent approaches to finely control the spatiotemporal release of bioactive molecules for various tissue engineering applications.
Journal ArticleDOI
Mesoporous silicon particles as intravascular drug delivery vectors: fabrication, in-vitro, and in-vivo assessments
TL;DR: The development of a multi-stage delivery vector that leverages its biocompatibility, biodegradability, ease of fabrication, tunable nanostructure, and porous network to enhance delivery of systemically administered therapeutic agents is presented.